Bank of America Corporation 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-10-06 4:26 pm Purchase | 2025-09-30 | 13G | Aptevo Therapeutics Inc. APVO | BANK OF AMERICA CORP BAC | 494,341 15.000% | 494,341![]() (New Position) | Filing |